Factors contributing to the efficacy of two add-on therapies of fesoterodine or mirabegron to silodosin monotherapy for persistent overactive bladder in men with lower urinary tract symptoms

被引：2
|
作者：
Matsukawa, Yoshihisa [1 ]
Gotoh, Momokazu [1 ]
机构：
[1] Nagoya Univ, Dept Urol, Grad Sch Med, Nagoya, Aichi, Japan
来源：
INTERNATIONAL JOURNAL OF UROLOGY | 2020年 / 27卷 / 01期
关键词：
D O I：
10.1111/iju.14117
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：85 / 86
页数：2
相关论文
共 50 条
  • [21] Re: Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder
    Kaplan, S. A.
    Roehrborn, C. G.
    Rovner, E. S.
    Carlsson, M.
    Bavendam, T.
    Guan, Z.
    EUROPEAN UROLOGY, 2007, 51 (06) : 1754 - 1754
  • [22] Current role of treatment in men with lower urinary tract symptoms combined with overactive bladder
    Lee, Seung Hwan
    Lee, Ji Youl
    PROSTATE INTERNATIONAL, 2014, 2 (02) : 43 - 49
  • [23] Efficacy and Safety of Flexible Dose Fesoterodine in Men and Women with Overactive Bladder Symptoms Including Nocturnal Urinary Urgency
    Weiss, Jeffrey P.
    Jumadilova, Zhanna
    Johnson, Theodore M., II
    FitzGerald, Mary P.
    Carlsson, Martin
    Martire, Diane L.
    Malhotra, Atul
    JOURNAL OF UROLOGY, 2013, 189 (04): : 1396 - 1401
  • [24] EFFICACY AND SAFETY OF MIRABEGRON VS. PLACEBO ADD-ON THERAPY IN MEN WITH OVERACTIVE BLADDER SYMPTOMS RECEIVING TAMSULOSIN FOR UNDERLYING BENIGN PROSTATIC HYPERPLASIA (PLUS)
    Kaplan, Steven
    Herschorn, Sender
    McVary, Kevin
    Staskin, David
    Chapple, Christopher
    Foley, Steve
    Cambronero Santos, Javier
    Kristy, Rita M.
    Choudhury, Nurul
    Hairston, John
    Schermer, Carol
    JOURNAL OF UROLOGY, 2019, 201 (04): : E992 - E992
  • [25] Efficacy and safety of muscarinic antagonists as add-on therapy for male lower urinary tract symptoms
    Li, Jinhong
    Shi, Qingquan
    Bai, Yunjin
    Pu, Chunxiao
    Tang, Yin
    Yuan, Haichao
    Wu, Yunjian
    Wei, Qiang
    Han, Ping
    SCIENTIFIC REPORTS, 2014, 4
  • [26] Efficacy and safety of muscarinic antagonists as add-on therapy for male lower urinary tract symptoms
    Jinhong Li
    Qingquan Shi
    Yunjin Bai
    Chunxiao Pu
    Yin Tang
    Haichao Yuan
    Yunjian Wu
    Qiang Wei
    Ping Han
    Scientific Reports, 4
  • [27] Desmopressin Add-On Therapy for Refractory Nocturia in Men Receiving α-Blockers for Lower Urinary Tract Symptoms
    Bae, Woong Jin
    Bae, Jang Ho
    Kim, Sae Woong
    Chung, Byung Ha
    Kim, Jang Hwan
    Kim, Choung Soo
    Lee, Hyun Moo
    Lee, Kyung Seop
    Yoo, Tag Keun
    Kim, Sun Il
    Byun, Seok Soo
    Lee, Ji Youl
    JOURNAL OF UROLOGY, 2013, 190 (01): : 180 - 186
  • [28] Persistence with solifenacin add-on therapy in men with benign prostate obstruction and residual symptoms of overactive bladder after tamsulosin monotherapy
    Lee, Y. -S.
    Lee, K. -S.
    Kim, J. C.
    Hong, S.
    Chung, B. H.
    Kim, C. -S.
    Lee, J. G.
    Kim, D. K.
    Park, C. H.
    Park, J. K.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2014, 68 (12) : 1496 - 1502
  • [29] EFFICACY OF TADALAFIL MONOTHERAPY AND ASSOCIATIONS BETWEEN CHANGES IN SUBJECTIVE OVERACTIVE BLADDER SYMPTOMS AND CHANGES IN OXIDATIVE STRESS IN PATIENTS WITH LOWER URINARY TRACT SYMPTOMS
    Matsuo, T.
    Miyata, Y.
    Araki, K.
    Nakamura, Y.
    Sagara, Y.
    Ohba, K.
    Sakai, H.
    NEUROUROLOGY AND URODYNAMICS, 2018, 37 : S394 - S394
  • [30] Prevalence of Constipation and Fecal Incontinence in Men and Women With Overactive Bladder and Lower Urinary Tract Symptoms
    Cash, Brooks D.
    Coyne, Karin S.
    Kopp, Zoe S.
    Gelhorn, Heather
    Berriman, Sandra
    Khullar, Vik
    GASTROENTEROLOGY, 2010, 138 (05) : S631 - S631
12345